114 related articles for article (PubMed ID: 8881764)
1. A defect in inducible beta-galactosidase of B lymphocytes in the osteopetrotic (mi/mi) mouse.
Yamamoto N; Naraparaju VR
Immunology; 1996 Aug; 88(4):604-10. PubMed ID: 8881764
[TBL] [Abstract][Full Text] [Related]
2. A defect in beta-galactosidase of B lymphocytes in the osteopetrotic (op/op) mouse.
Yamamoto N; Naraparaju VR
Immunol Lett; 1996 Apr; 50(1-2):35-40. PubMed ID: 8793557
[TBL] [Abstract][Full Text] [Related]
3. A defect in the inflammation-primed macrophage-activation cascade in osteopetrotic rats.
Yamamoto N; Lindsay DD; Naraparaju VR; Ireland RA; Popoff SN
J Immunol; 1994 May; 152(10):5100-7. PubMed ID: 8176226
[TBL] [Abstract][Full Text] [Related]
4. Role of vitamin D3-binding protein in activation of mouse macrophages.
Yamamoto N; Naraparaju VR
J Immunol; 1996 Aug; 157(4):1744-9. PubMed ID: 8759764
[TBL] [Abstract][Full Text] [Related]
5. Roles of beta-galactosidase of B lymphocytes and sialidase of T lymphocytes in inflammation-primed activation of macrophages.
Naraparaju VR; Yamamoto N
Immunol Lett; 1994 Dec; 43(3):143-8. PubMed ID: 7721326
[TBL] [Abstract][Full Text] [Related]
6. Vitamin D3-binding protein as a precursor for macrophage activating factor in the inflammation-primed macrophage activation cascade in rats.
Yamamoto N; Naraparaju VR
Cell Immunol; 1996 Jun; 170(2):161-7. PubMed ID: 8660814
[TBL] [Abstract][Full Text] [Related]
7. The toothless osteopetrotic rat has a normal vitamin D-binding protein-macrophage activating factor (DBP-MAF) cascade and chondrodysplasia resistant to treatments with colony stimulating factor-1 (CSF-1) and/or DBP-MAF.
Odgren PR; Popoff SN; Safadi FF; MacKay CA; Mason-Savas A; Seifert MF; Marks SC
Bone; 1999 Aug; 25(2):175-81. PubMed ID: 10456382
[TBL] [Abstract][Full Text] [Related]
8. Vitamin D3 binding protein (group-specific component) is a precursor for the macrophage-activating signal factor from lysophosphatidylcholine-treated lymphocytes.
Yamamoto N; Homma S
Proc Natl Acad Sci U S A; 1991 Oct; 88(19):8539-43. PubMed ID: 1924312
[TBL] [Abstract][Full Text] [Related]
9. Conversion of vitamin D3 binding protein (group-specific component) to a macrophage activating factor by the stepwise action of beta-galactosidase of B cells and sialidase of T cells.
Yamamoto N; Kumashiro R
J Immunol; 1993 Sep; 151(5):2794-802. PubMed ID: 8360493
[TBL] [Abstract][Full Text] [Related]
10. Defective lymphocyte glycosidases in the macrophage activation cascade of juvenile osteopetrosis.
Yamamoto N; Naraparaju VR; Orchard PJ
Blood; 1996 Aug; 88(4):1473-8. PubMed ID: 8695868
[TBL] [Abstract][Full Text] [Related]
11. Vitamin D-binding protein (group-specific component) is the sole serum protein required for macrophage activation after treatment of peritoneal cells with lysophosphatidylcholine.
Homma S; Yamamoto M; Yamamoto N
Immunol Cell Biol; 1993 Aug; 71 ( Pt 4)():249-57. PubMed ID: 8225394
[TBL] [Abstract][Full Text] [Related]
12. Activation of peritoneal macrophages by lysophosphatidylcholine.
Ngwenya BZ; Yamamoto N
Biochim Biophys Acta; 1985 Mar; 839(1):9-15. PubMed ID: 3978122
[TBL] [Abstract][Full Text] [Related]
13. Structurally well-defined macrophage activating factor derived from vitamin D3-binding protein has a potent adjuvant activity for immunization.
Yamamoto N; Naraparaju VR
Immunol Cell Biol; 1998 Jun; 76(3):237-44. PubMed ID: 9682967
[TBL] [Abstract][Full Text] [Related]
14. Contribution of lysophosphatidylcholine-treated nonadherent cells to mechanism of macrophage activation.
Ngwenya BZ; Yamamoto N
Proc Soc Exp Biol Med; 1990 Feb; 193(2):118-24. PubMed ID: 2300592
[TBL] [Abstract][Full Text] [Related]
15. Identification of the serum factor required for in vitro activation of macrophages. Role of vitamin D3-binding protein (group specific component, Gc) in lysophospholipid activation of mouse peritoneal macrophages.
Yamamoto N; Homma S; Millman I
J Immunol; 1991 Jul; 147(1):273-80. PubMed ID: 2051023
[TBL] [Abstract][Full Text] [Related]
16. Partial rescue of B cells in microphthalmic osteopetrotic marrow by loss of response to type I IFNs.
Roundy KM; Spangrude G; Weis JJ; Weis JH
Int Immunol; 2005 Nov; 17(11):1495-503. PubMed ID: 16186160
[TBL] [Abstract][Full Text] [Related]
17. Immune function in congenital osteopetrosis: defective lymphocyte function in microphthalmic mice.
Minkin C; Trump G; Stohlman SA
Dev Comp Immunol; 1982; 6(1):151-9. PubMed ID: 6978266
[TBL] [Abstract][Full Text] [Related]
18. Combination macrophage-colony stimulating factor and interferon-gamma administration ameliorates the osteopetrotic condition in microphthalmic (mi/mi) mice.
Rodriguiz RM; Key LL; Ries WL
Pediatr Res; 1993 Apr; 33(4 Pt 1):384-9. PubMed ID: 8479820
[TBL] [Abstract][Full Text] [Related]
19. Participation of serum proteins in the inflammation-primed activation of macrophages.
Yamamoto N; Willett NP; Lindsay DD
Inflammation; 1994 Jun; 18(3):311-22. PubMed ID: 8088927
[TBL] [Abstract][Full Text] [Related]
20. Effects of inflammation products on immune systems. Lysophosphatidylcholine stimulates macrophages.
Ngwenya BZ; Yamamoto N
Cancer Immunol Immunother; 1986; 21(3):174-82. PubMed ID: 2938735
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
